期刊
INTERNAL MEDICINE
卷 55, 期 22, 页码 3273-3277出版社
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.55.7035
关键词
tolvaptan; liver cirrhosis; refractory ascites; delayed response
资金
- Grants-in-Aid for Scientific Research [15K09028] Funding Source: KAKEN
The patient was a 67-year-old female with liver cirrhosis due to hepatitis C. She was administered furosemide at 20 mg/day and spironolactone at 25 mg/day, but the ascites did not improve. Despite the additional administration of tolvaptan at 3.75 mg/day, the response to ascites was still poor. While the dose of tolvaptan was thereafter increased to 7.5 mg/day on the 7th hospital day, the ascites still persisted. However, she continued to receive tolvaptan (7.5 mg/day) because the worsening of her subjective symptoms was mild and she wished to do so. The ascites was later found to have almost completely disappeared on computed tomography (CT) at 6 months.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据